Ellsworth Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
RIM
GCM
CAM
Ellsworth Advisors's LMAT Position: Q4 2023 in Review
Ellsworth Advisors sold out of LeMaitre Vascular (LMAT) in Q4 2023, closing a stake of 6,344 shares — an estimated $306K sold.
Ellsworth Advisors first reported a position in LMAT in Q2 2021 and held it in 4 quarters. The position peaked at $567K in Q2 2021. 227 funds tracked by Wall St. Rank hold LMAT as of Q4 2023.
- Ellsworth Advisors reported no remaining LeMaitre Vascular position as of Q4 2023 after selling out during the quarter.
- Ellsworth Advisors sold 6,344 LeMaitre Vascular shares in Q4 2023, an estimated $306K.
- Ellsworth Advisors first reported a position in LeMaitre Vascular in Q2 2021 and held it in 4 quarters.
- Ellsworth Advisors's LeMaitre Vascular position peaked at $567K in Q2 2021.
- 227 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2023.
Based on Ellsworth Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.